Latest C-Path Stories
The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc.
Global organizations convene cross-sector thought leaders to discuss public-private partnerships BETHESDA, Md., Dec.
New multi-year grant continues work to study pressing public health crisis TUCSON, Ariz., Sept.
New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept.
The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the launch of the Coalition For Accelerating Standards and Therapies (CFAST), a follow-up
Critical Path Institute and CDISC (Clinical Data Interchange Standards Consortium) announce the availability of a breakthrough tool to help combat tuberculosis (TB)—a persistent disease resulting
Critical Path Institute (C-Path) and Clinical Data Interchange Standards Consortium (CDISC) announced the release of version 1.0 of the Alzheimerâ€™s disease (AD) Therapeutic Area Standard (SDTM
First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases; Shared Resource from Unique Public-Private Partnership Will Help Accelerate Alzheimer's, Parkinson's, and Other Brain Disease Research WASHINGTON, June 11 /PRNewswire-USNewswire/ -- A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials will be released today by the Coalition Against Major Diseases (CAMD).
By Dale Quinn, The Arizona Daily Star, Tucson Jun.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.